a decreasing trendP < .07
The baseline C‐peptide levels were relatively low compared with the normal range and regardless of the duration of T2DM and the patients' BMI, and a decreasing trend in the levels of C‐peptide was observed after administration, particularly in patients with a T2DM history of 10 years ( P < .07; Table 2 ).